Education

Pediatric Tumor Board

The pediatric tumor Board meets every Wednesday. Patients with common diagnoses such as leukemia, lymphoma, sarcoma, and brain tumors are presented for diagnostic review and discussion of management options. This is a weekly multidisciplinary conference in which experts in pathology, genetics, surgery, radiology and psychology discuss the latest diagnostic and treatment information in pediatric cancer. This forum ensures that each case receives focused attention and review in order to maximize treatment options and enrollment in clinical trials. As a service to other healthcare providers, pediatric tumor board is open to all San Antonio pediatric specialists dealing with children’s cancer. For more information contact Dr. Shafqat Shah.

Pediatric Hematology Conference

Periodically during the Tumor Board time slot, hematology topics are presented by fellows and hematology faculty. Topics are chosen based on a clinical scenario and included hemophilia/bleeding disorders, hemoglobinopathies, thrombosis, and other rate blood disorders.

Senior Electives

An approved senior selective for fourth year medical students is offered, catalog number PEDI 4013. Students participate in inpatient service and outpatient clinics in hematology, oncology, and immunology. Emphasis is placed on acquiring and enhancing skills needed in the diagnostic evaluation, therapy and follow-up of these subspecialty patients.

Research Electives

Interested medical students and residents are encouraged to contact individual faculty regarding specialized research electives. Currently active research programs include cancer genetics, epidemiology, cardiac late effects, leukemia, health services, delivery research, pediatric drug discovery research and pediatric liver tumors. Global Pediatric Hematology and Oncology educational opportunities are available through our Global Health Programs.

Pediatric Hematology-Oncology Fellowship Program

The division’s fellowship program was began in 2008 and has now successfully graduated 15 fellows. At our first site visit in 2011 we received a commendation from the ACGME and have ongoing accredited through 2027 without citations. The fellowship consists of one clinical year followed by two years of research which takes place primarily at the Greehey Children’s Cancer Research Institute.

Learn more about our Hematology-Oncology Fellowship